The new SPAC intends to focus its initial search on target businesses in the healthcare sector with an enterprise value of approximately $500 million to $2 billion. NorthView is led by Co-Founder and CEO Jack Stover, Co-Founder and CFO Fred Knechtel, and Chairman of the Board Peter O’Rourke.
Total SPAC deal count for 2021 year-to-date is now 607. This offering is expected to close on Wednesday, December 22.
I-Bankers Securities, Inc. is acting as the sole book-running manager of the offering and Dawson James Securities, Inc. is acting as co-manager of the offering. Schiff Hardin LLP is serving as Issuer’s Counsel with Ellenoff Grossman & Schole LLP serving as Underwriter’s Counsel. Marcum LLP serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.